Delphine V.
- Country
- France
- Department
- Endocrinologie
Research Overview
- Efficacy of Metyrapone in Patients with Primary Bilateral Macronodular Adrenal Hyperplasia and Mild Autonomous Cortisol Secretion: A Randomized Controlled Trial
- Adjuvant mitotane vs. mitotane with cisplatin/etoposide after primary surgical resection of localised adrenocortical carcinoma with high risk of recurrence (ADIUVO-2 Trial): A pragmatic, randomised, low-intervention phase III, clinical trial with an observational arm.
Data & Insights
Has run more than one trial at 4 of 29 partner sites.
Specializations
Endocrine Oncology
The investigator specializes in the treatment and management of adrenocortical carcinoma, focusing on developing effective therapeutic strategies for patients with high-risk profiles.
- Adrenal Cancer Treatment
- Post-Surgical Care
- Risk Stratification
The investigator explores therapeutic approaches in endocrine oncology, particularly focusing on adjuvant treatment modalities for adrenal tumors.
Treatment Innovation
The researcher concentrates on advancing combination therapy approaches in endocrine oncology, investigating the integration of different treatment modalities for optimal patient outcomes.
- Targeted Therapies
- Combined Treatment Strategies
- Therapeutic Optimization
Their work encompasses the evaluation of various therapeutic combinations to enhance treatment efficacy in aggressive endocrine cancers.
Clinical Management
The investigator focuses on developing adjuvant treatment protocols for patients following surgical intervention, with particular attention to high-risk cases requiring comprehensive care approaches.
- Post-Operative Care
- Risk Assessment
- Treatment Planning
Their expertise extends to establishing evidence-based treatment pathways for complex endocrine cancer cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.